FDA Inspection
Kansas City Oncology Program IRBKansas City Oncology Program IRB – FDA Inspection, Mar 15, 2018
Record Details
This FDA Inspection record concerns Kansas City Oncology Program IRB, with an inspection on March 15, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e8b3303f-6973-4037-99cc-06b394230d0c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1044348
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 56.115(a)(2)Minutes of IRB meetings
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kansas City Oncology Program IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 26, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Kansas City Oncology Program IRB
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.